ClinicalTrials.govpublic full text
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
early t acute lymphoblastic leukemia, t-acute lymphoblastic leukemia, mixed phenotype acute leukemia, t/myeloid, nos, adverse risk, newly diagnosed, induction therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1009630
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.